comparemela.com

Jamesl Januzzi News Today : Breaking News, Live Updates & Top Stories | Vimarsana

New Drug Aids Exercise, Tasks for Common Heart Condition Patients

New Drug Aids Exercise, Tasks for Common Heart Condition Patients
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

United statesIacopo olivottoMichael aradMarion van sinttruijeLubna choudhuryLisa mengJacob tfelt hansenBrian claggettJamesl januzziJosef veselkaMichaele nassifArtur oreziakPablo garcia paviaAmy wohltmanHugh watkinsStephenb heitner

Empagliflozin did not cut risk for death, HF hospitalization after heart attack: EMPACT-MI

Empagliflozin did not cut risk for death, HF hospitalization after heart attack: EMPACT-MI
healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.

United statesBykatie kalvaitisJaved butlerBaylor scottJamesl januzziBoehringer ingelheim eli lillyErik swainPatrickt ogaraBaim institute for clinical researchWhite research instituteAmerican college of cardiology scientific sessionUniversity of mississippiWhite healthEli lillyAmerican collegeCardiology scientific session

REMS Program Resources for Clinicians

An expert cardiologist discusses the importance of healthcare provider education and finding resources around the REMS program.

United statesJamesl januzziHospital heart centerDrug administrationRisk evaluationMitigation strategyUnited states foodMassachusetts general hospital heart centerObstructive hypertrophic cardiomyopathy

Role of Mavacamten in Treating oHCM

James L. Januzzi, MD, comments on mavacamten as the first approved cardiac myosin inhibitor for oHCM, balancing the increased risk of heart failure with the medication, and the role of the REMS program.

Jamesl januzziRisk evaluationMitigation strategy

Using Cardiac Myosin Inhibitors for the Treatment of oHCM

Dr James L. Januzzi reviews the use of cardiac myosin inhibitors for the management of oHCM.

Jamesl januzziCardiac myosin inhibitorsTreatment of ohcmObstructive hypertrophic cardiomyopathy

vimarsana © 2020. All Rights Reserved.